Showing 2771-2780 of 5646 results for "".
- Genentech: Pivotal Phase 3 Data for Neuromyelitis Optica Spectrum Disorder (Devic’s Disease)https://modernod.com/news/genentech-pivotal-phase-3-data-for-neuromyelitis-optica-spectrum-disorder-devics-disease/2476566/Genentech presented new pivotal phase 3 data for the rare autoimmune disease neuromyelitis optica spectrum disorder (NMOSD), also known as Devic’s Disease, for which there are no approved treatments. NMOSD is a rare, lifelong and debilitating autoimmune disease of the c
- Earlier Detection of Diabetic Retinopathy with Smartphone AIhttps://modernod.com/news/earlier-detection-of-diabetic-retinopathy-with-smartphone-ai/2476559/A novel pairing of two technologies may offer a solution for better screening for diabetic ret
- Ophtec Receives FDA Approval for RingJect Design Enhancementshttps://modernod.com/news/ophtec-receives-fda-approval-for-ringject-design-enhancements/2476536/Ophtec USA received FDA approval for the RingJect delivery system design optimization changes. Ophtec’s RingJect is a single use injector preloaded with the Ophtec Capsular Tension Ring (CTR). The Ophtec CTR is made of PMMA with patented compression molding technology, making for a durable
- IBM’s New AI Technique Could Detect Glaucoma Earlierhttps://modernod.com/news/ibms-new-ai-technique-could-detect-glaucoma-earlier/2476530/At ARVO, IBM researchers presented new techniques in deep learning that could help unlock earlier glaucoma detection. IBM and NYU’s research demonstrates how deep learning models can be trained to learn from and analyze easily-obtained retina images, and then use this analysis to directly estimat
- RadianceTx Expands Team to Develop Beta Ophthalmic Systemhttps://modernod.com/news/radiancetx-expands-team-to-develop-beta-ophthalmic-system/2476511/Radiance Therapeutics has announced the expansion of its core team. Abigail Mackrill, formerly of Ophthalmology Futures Forums and The Ophthalmologist, joins as Director of Business Development and Outreach. James Fazio, MBA, Msc Eng, formerly Global Business Leader for
- Novaliq and BLP Management Group Establish New Company, Betaliq, to Leverage EyeSol Technology to Treat Glaucomahttps://modernod.com/news/novaliq-and-blp-management-group-establish-new-company-betaliq-to-leverage-eyesol-technology-to-treat-glaucoma/2476500/Novaliq and BLP Management group announced the formation and funding of Betaliq. The Tampa-based company’s pipeline consists of two preservative-free glaucoma drug candidates based on new in class and best in class ß-blocker molecules using Novaliq’s waterfree EyeSol technology. Two EyeSol-
- LIGHTMED Appoints Lee Walker-Roberts as Global Business Development Directorhttps://modernod.com/news/lightmed-appoints-lee-walker-roberts-as-global-business-development-director/2476484/LIGHTMED announced the appointment of Lee Walker-Roberts as Global Business Development Director, effective immediately. Mr. Walker-Roberts is an experienced leader and executive advisor for high-tech companies ranging from privately-owned start-ups to companies with over $200 million in annual s
- US Military Develops Mobile Application to Treat Eye Injurieshttps://modernod.com/news/us-military-develops-mobile-application-to-treat-eye-injuries/2476479/The U.S. military medical researchers are developing a mobile application to connect combat medics with on-call ophthalmologists either in-theater or at a clinic to treat eye injuries of soldiers in the field, according to a
- Fraunhofer IAP Developing Contact lenses With Medicine and Sugarhttps://modernod.com/news/fraunhofer-iap-developing-contact-lenses-with-medicine-and-sugar/2476476/Researchers at the Fraunhofer Institute for Applied Polymer Research IAP are working with Israeli and German partners to develop long-wearing contact lenses that can release medicine. The active ingredient is encapsulated in liposomes and bound to the inside of the contact lenses. This enables it
- NovaBay Pharmaceuticals Announces New Partner Pharmacy Programhttps://modernod.com/news/novabay-pharmaceuticals-announces-new-partner-pharmacy-program/2476465/NovaBay Pharmaceuticals announced a new pharmacy partnering program in an effort to ensure all patients in the United States have reliable and affordable access to prescription Avenova, according to a company news release. NovaBay has recently added six new pharmacies as Avenova channel partners.